Apple Hospitality REIT extends share repurchase program to July 2027 with $242.5M authorization

Apple Hospitality REIT, Inc.

Board extended share repurchase program through July 2027, authorizing up to $242.5M in common share buybacks.
Repurchases may be executed via open market, 10b5-1 plans, or private transactions, subject to market conditions.
At the May 22, 2026 Annual Meeting, all eight director nominees were elected; KPMG ratified as auditor; say-on-pay passed.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-241917
form_type: 8-K
ticker: APLE
cik: 0001418121
company_name: Apple Hospitality REIT, Inc.
filed_at: 2026-05-27T20:15:15+00:00
discovered_at: 2026-05-27T20:16:00.309462+00:00
generated_at: 2026-05-27T20:18:30.734205+00:00
sec_items: ["5.07", "8.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-241917
json_url: https://secwatch.observer/filing/0001193125-26-241917.json
markdown_url: https://secwatch.observer/filing/0001193125-26-241917.md
text_url: https://secwatch.observer/filing/0001193125-26-241917.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1418121/000119312526241917/0001193125-26-241917-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1418121/000119312526241917/aple-20260522.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed

Rising Dragon Acquisition Corp. June 1, 2026, 6:08 AM ET other_material Items 1.01, 5.03, 5.07, 8.01, 9.01

same SEC item: 5.07, 8.01 same event type: other_material similar materiality

Dime Commercial Bancshares name change effective; three executives amend employment agreements

Dime Community Bancshares, Inc. /NY/ June 1, 2026, 4:02 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same SEC item: 5.07 same event type: other_material similar materiality

Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030

Spyre Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01